← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1999Last known activity
Apr 25, 2023
Timeline
1970s
- Jun 1, 1971
FHI 360— Founded
Drugs by trial phase (25 distinct, 37 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Chikungunya Fever
- Chlamydia Infections
- Communicable Diseases
- Flaviviridae Infections
- Flavivirus Infections
- Gonorrhea
- HIV Infections
- Infections
- Influenza, Human
- Influenza in Birds
- Malaria
- RNA Virus Infections
- Syphilis
- Trichomonas Vaginitis
- Vaginitis
- Virus Diseases
- Zika Virus Infection
Recent trials (50)
- NCT05871060CollaboratorN/AApr 25, 2023
- NCT05174884Lead sponsorPhase 1Nov 30, 2022
- NCT05174884Overall official - principal investigatorPhase 1Nov 30, 2022
- NCT05458765CollaboratorPhase 2Jun 21, 2022
- NCT05016895Overall official - principal investigatorN/AAug 27, 2021
- NCT05016895Lead sponsorN/AAug 27, 2021
- NCT04682353CollaboratorPhase 1Dec 14, 2020
- NCT04617626Lead sponsorN/ANov 15, 2020
- NCT03700658CollaboratorPhase 1Dec 14, 2018
- NCT03255941Lead sponsorEarly Phase 1Mar 19, 2018
- NCT03255941Overall official - principal investigatorEarly Phase 1Mar 19, 2018
- NCT03255941OfficialEarly Phase 1Mar 19, 2018
- NCT03154125Lead sponsorPhase 3Jul 30, 2017
- NCT03154125Study directorPhase 3Jul 30, 2017
- NCT03110770CollaboratorPhase 2Mar 29, 2017
Details
- Founded
- Durham, NC, US Jun 1, 1971
- Last known activity
- Apr 25, 2023